José Federico
Díaz González
Catedrático de Universidad
Iván Alejandro
Ferraz Amaro
Publicaciones en las que colabora con Iván Alejandro Ferraz Amaro (25)
2024
-
The complement system is linked to insulin resistance in patients with systemic lupus erythematosus
Clinical and experimental rheumatology, Vol. 42, Núm. 1, pp. 115-121
2023
-
Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus
Frontiers in Immunology, Vol. 14
-
HDL Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus
Journal of Clinical Medicine, Vol. 12, Núm. 16
-
Tocilizumab-related hypertriglyceridemia is independent of key molecules regulating lipid metabolism
European Journal of Clinical Investigation, Vol. 53, Núm. 9
2021
-
Differences in Capacity of High-Density Lipoprotein Cholesterol Efflux Between Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis
Arthritis Care and Research, Vol. 73, Núm. 11, pp. 1590-1596
-
HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis
Arthritis Research and Therapy, Vol. 23, Núm. 1
-
Impact of Disease Activity on Physical Activity in Patients With Psoriatic Arthritis
Arthritis Care and Research, Vol. 73, Núm. 12, pp. 1834-1844
2020
-
HDL cholesterol efflux capacity is related to disease activity in psoriatic arthritis patients
Clinical Rheumatology, Vol. 39, Núm. 6, pp. 1871-1880
-
Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis
Rheumatology (Oxford, England), Vol. 59, Núm. 10, pp. 2847-2856
-
Proprotein convertase subtilisin/kexin type 9 in patients with systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 38, pp. S18-S24
2019
-
Effect of IL-6 Receptor Blockade on Proprotein Convertase Subtilisin/Kexin Type-9 and Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients
Hormone and Metabolic Research, Vol. 51, Núm. 3, pp. 200-209
2017
-
HDL cholesterol efflux capacity in rheumatoid arthritis patients: Contributing factors and relationship with subclinical atherosclerosis
Arthritis Research and Therapy, Vol. 19, Núm. 1
2015
-
Relationship between endothelial dysfunction and osteoprotegerin, vitamin D, and bone mineral density in patients with rheumatoid arthritis
Clinical and Experimental Rheumatology, Vol. 33, Núm. 2, pp. 241-249
-
Relationship of abdominal adiposity and body composition with endothelial dysfunction in patients with rheumatoid arthritis
Clinical and Experimental Rheumatology, Vol. 33, Núm. 4, pp. 516-523
2014
-
Influence of disease activity on the physical activity of rheumatoid arthritis patients
Rheumatology (United Kingdom), Vol. 53, Núm. 4, pp. 722-731
-
Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: Scientific evidence and expert opinion
Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 1, pp. 1-8
-
Retinol-binding protein 4 in rheumatoid arthritis-related insulin resistance and β-cell function
Journal of Rheumatology, Vol. 41, Núm. 4, pp. 658-665
2013
-
Cholesteryl ester transfer protein in patients with rheumatoid arthritis
Journal of Rheumatology, Vol. 40, Núm. 7, pp. 1040-1047
2012
-
Impaired beta cell function is present in nondiabetic rheumatoid arthritis patients
Arthritis Research and Therapy, Vol. 15, Núm. 1
2011
-
Mujer con artralgias y aumento de tamaño de miembros superiores
Reumatologia Clinica, Vol. 7, Núm. 3, pp. 210-211